S21-379 Development of Novel Chemical Entities for Inhibition of the Protein Kinases Involved in Cell Death, Neurodegeneration and Cancer Stanford researchers have developed potent protein Kinase inhibitors for inhibition of pathological activity of protein kinases involved in cell death, inflammation and cancer. Michael Green Alam Jahangir Denise Briggs Alex Ferris Mehrdad Shamloo Matteo Santoro